InVitria and biopharmaceutical industry leaders at Biomanufacturing Summit in La Jolla, California January 26^th and 27^th, 2010.

Fort Collins, CO January 27, 2010 / b3c newswire / – As one of the leading innovators in biomanufacturing technology, InVitria’s products enable its customers to optimize their biomanufacturing process from the cell bank through downstream purification.

Biomanufacturing Summit brings thought leaders together to address the major issues facing the biopharmaceutical industry today, including product quality, consistency and cost effectiveness. InVitria’s line of defined and performance maximizing cell culture products are designed to solve these challenges.

“InVitria is pleased to once again serve as a sponsor for Biomanufacturing Summit,” said Scott Deeter, InVitria President and CEO. “This event is a great opportunity to collaborate with existing biopharma customers and identify new opportunities to deliver integrated solutions that optimize mammalian cell culture and viral vaccine manufacturing.”

One of InVitria’s newly developed products for biomanufacturers is Zap-CHO, a robust CHO cell line supplement designed to improve CHO growth and productivity and simultaneously improve downstream purification efficiency. To view an online video featuring the benefits of Zap-CHO, click here.

Cellastim and Lacromin, two of InVitria’s other performance enhancing cell culture supplements, will be highlighted in a presentation by Dr. Matt Croughan, Director of the Amgen Bioprocessing Center at the Keck Graduate Institute.  To receive a copy of Dr. Croughan’s presentation, please contact InVitria.
 

About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media supplements and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

To request more information about InVitria’s products, e-mail info@InVitria.com or call 1-800-916-8311.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.